Dermal group 2 innate lymphoid cells in atopic dermatitis and allergy

Current Opinion in Immunology

Volumn 31, Issue , 2014, Pages 108-114

  Roediger, Ben ^a,b   Kyle, Ryan ^c   Le Gros, Graham ^c,d   Weninger, Wolfgang ^a,b,e  

^a CENTENARY INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^d VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FILAGGRIN; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 25; INTERLEUKIN 3; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; THYMIC STROMAL LYMPHOPOIETIN; UVOMORULIN;

ADAPTIVE IMMUNITY; ARTICLE; ATOPIC DERMATITIS; CELL MIGRATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE SEVERITY; EPITHELIUM CELL; GROUP 2 INNATE LYMPHOID CELL; GROUP 3 INNATE LYMPHOID CELL; HUMAN; INFLAMMATION; LYMPHOID CELL; MAST CELL; NONHUMAN; PATHOGENESIS; SKIN ALLERGY; TH2 CELL; ANIMAL; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE; MOUSE; PATHOLOGY; SKIN; URTICARIA;

ANIMALS; DERMATITIS, ATOPIC; HUMANS; IMMUNITY, INNATE; LYMPHOCYTES; MICE; SKIN; URTICARIA;

EID: 84908574546     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.10.008     Document Type: Review

References (68)

1. Bieber T. Atopic dermatitis. N Engl J Med 2008, 358:1483-1494.
2. Liu F.T., Goodarzi H., Chen H.Y. IgE, mast cells, and eosinophils in atopic dermatitis. Clin Rev Allergy Immunol 2011, 41:298-310.
3. Spergel J.M. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol 2010, 105:99-106. quiz 107-109, 117.
4. Gustafsson D., Sjoberg O., Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis-a prospective follow-up to 7 years of age. Allergy 2000, 55:240-245.
5. Spits H., Artis D., Colonna M., Diefenbach A., Di Santo J.P., Eberl G., Koyasu S., Locksley R.M., McKenzie A.N., Mebius R.E., et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 2013, 13:145-149.
6. Moro K., Yamada T., Tanabe M., Takeuchi T., Ikawa T., Kawamoto H., Furusawa J., Ohtani M., Fujii H., Koyasu S. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010, 463:540-544.
7. Satoh-Takayama N., Lesjean-Pottier S., Vieira P., Sawa S., Eberl G., Vosshenrich C.A., Di Santo J.P. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J Exp Med 2010, 207:273-280.
8. Spits H., Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 2012, 30:647-675.
9. Hoyler T., Klose C.S., Souabni A., Turqueti-Neves A., Pfeifer D., Rawlins E.L., Voehringer D., Busslinger M., Diefenbach A. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 2012, 37:634-648.
10. Mjosberg J., Bernink J., Golebski K., Karrich J.J., Peters C.P., Blom B., te Velde A.A., Fokkens W.J., van Drunen C.M., Spits H. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 2012, 37:649-659.
11. Neill D.R., Wong S.H., Bellosi A., Flynn R.J., Daly M., Langford T.K., Bucks C., Kane C.M., Fallon P.G., Pannell R., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367-1370.
12. Price A.E., Liang H.E., Sullivan B.M., Reinhardt R.L., Eisley C.J., Erle D.J., Locksley R.M. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A 2010, 107:11489-11494.
13. Chang Y.J., Kim H.Y., Albacker L.A., Baumgarth N., McKenzie A.N., Smith D.E., Dekruyff R.H., Umetsu D.T. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011, 12:631-638.
14. Monticelli L.A., Sonnenberg G.F., Abt M.C., Alenghat T., Ziegler C.G., Doering T.A., Angelosanto J.M., Laidlaw B.J., Yang C.Y., Sathaliyawala T., et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011, 12:1045-1054.
15. Kim B.S., Siracusa M.C., Saenz S.A., Noti M., Monticelli L.A., Sonnenberg G.F., Hepworth M.R., Van Voorhees A.S., Comeau M.R., Artis D. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 2013, 5:170ra116.
16. Roediger B., Kyle R., Yip K.H., Sumaria N., Guy T.V., Kim B.S., Mitchell A.J., Tay S.S., Jain R., Forbes-Blom E., et al. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat Immunol 2013, 14:564-573.
17. Molofsky A.B., Nussbaum J.C., Liang H.E., Van Dyken S.J., Cheng L.E., Mohapatra A., Chawla A., Locksley R.M. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med 2013, 210:535-549.
18. Mjosberg J.M., Trifari S., Crellin N.K., Peters C.P., van Drunen C.M., Piet B., Fokkens W.J., Cupedo T., Spits H. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011, 12:1055-1062.
19. Teunissen M.B., Munneke J.M., Bernink J.H., Spuls P.I., Res P.C., Te Velde A., Cheuk S., Brouwer M.W., Menting S.P., Eidsmo L., et al. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR ILC3 in lesional skin and blood of psoriasis patients. J Investig Dermatol 2014, 134:2351-2360.
20. Meylan F., Hawley E.T., Barron L., Barlow J.L., Penumetcha P., Pelletier M., Sciume G., Richard A.C., Hayes E.T., Gomez-Rodriguez J., et al. The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells. Mucosal Immunol 2013, 7:958-968.
21. Yu X., Pappu R., Ramirez-Carrozzi V., Ota N., Caplazi P., Zhang J., Yan D., Xu M., Lee W.P., Grogan J.L. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunol 2014, 7:730-740.
22. Kabata H., Moro K., Fukunaga K., Suzuki Y., Miyata J., Masaki K., Betsuyaku T., Koyasu S., Asano K. Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation. Nat Commun 2013, 4:2675.
23. Barnig C., Cernadas M., Dutile S., Liu X., Perrella M.A., Kazani S., Wechsler M.E., Israel E., Levy B.D. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med 2013, 5:174ra126.
24. Doherty T.A., Khorram N., Lund S., Mehta A.K., Croft M., Broide D.H. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. J Allergy Clin Immunol 2013, 132:205-213.
25. Xue L., Salimi M., Panse I., Mjosberg J.M., McKenzie A.N., Spits H., Klenerman P., Ogg G. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol 2014, 133. 1184-1194 e1187.
26. Wilhelm C., Hirota K., Stieglitz B., Van Snick J., Tolaini M., Lahl K., Sparwasser T., Helmby H., Stockinger B. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol 2011, 12:1071-1077.
27. Zaiss D.M., Yang L., Shah P.R., Kobie J.J., Urban J.F., Mosmann T.R. Amphiregulin, a TH2 cytokine enhancing resistance to nematodes. Science 2006, 314:1746.
28. Hams E., Armstrong M.E., Barlow J.L., Saunders S.P., Schwartz C., Cooke G., Fahy R.J., Crotty T.B., Hirani N., Flynn R.J., et al. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proc Natl Acad Sci U S A 2014, 111:367-372.
29. Liang H.E., Reinhardt R.L., Bando J.K., Sullivan B.M., Ho I.C., Locksley R.M. Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat Immunol 2012, 13:58-66.
30. Bartemes K.R., Kephart G.M., Fox S.J., Kita H. Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol 2014, 134. 671-678 e674.
31. Dyring-Andersen B., Geisler C., Agerbeck C., Lauritsen J.P., Gudjonsdottir S.D., Skov L., Bonefeld C.M. Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin. Br J Dermatol 2014, 170:609-616.
32. + ILC3 in psoriasis. J Investig Dermatol 2014, 134:984-991.
33. Spencer S.P., Wilhelm C., Yang Q., Hall J.A., Bouladoux N., Boyd A., Nutman T.B., Urban J.F., Wang J., Ramalingam T.R., et al. Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science 2014, 343:432-437.
34. Imai Y., Yasuda K., Sakaguchi Y., Haneda T., Mizutani H., Yoshimoto T., Nakanishi K., Yamanishi K. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl Acad Sci U S A 2013, 110:13921-13926.
35. Tong P.L., Roediger B., Kolesnikoff N., Biro M., Tay S.S., Jain R., Shaw L.E., Grimbaldeston M.A., Weninger W. The skin immune atlas: three-dimensional analysis of cutaneous leukocyte subsets by multiphoton microscopy. J Investig Dermatol 2014, 10.1038/jid.2014.289.
36. Salimi M., Barlow J.L., Saunders S.P., Xue L., Gutowska-Owsiak D., Wang X., Huang L.C., Johnson D., Scanlon S.T., McKenzie A.N., et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 2013, 210:2939-2950.
37. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., Goudie D.R., Sandilands A., Campbell L.E., Smith F.J., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006, 38:441-446.
38. Weidinger S., Illig T., Baurecht H., Irvine A.D., Rodriguez E., Diaz-Lacava A., Klopp N., Wagenpfeil S., Zhao Y., Liao H., et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006, 118:214-219.
39. Marenholz I., Nickel R., Ruschendorf F., Schulz F., Esparza-Gordillo J., Kerscher T., Gruber C., Lau S., Worm M., Keil T., et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 2006, 118:866-871.
40. Kim B.S., Wojno E.D., Artis D. Innate lymphoid cells and allergic inflammation. Curr Opin Immunol 2013, 25:738-744.
41. Howell M.D., Gallo R.L., Boguniewicz M., Jones J.F., Wong C., Streib J.E., Leung D.Y. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 2006, 24:341-348.
42. Bos J.D., Wierenga E.A., Sillevis Smitt J.H., van der Heijden F.L., Kapsenberg M.L. Immune dysregulation in atopic eczema. Arch Dermatol 1992, 128:1509-1512.
43. Plaut M. Antigen-specific lymphokine secretory patterns in atopic disease. J Immunol 1990, 144:4497-4500.
44. + memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA-memory T cells. J Immunol 1997, 159:4611-4619.
45. Van der Ploeg I., Jeddi Tehrani M., Matuseviciene G., Wahlgren C.F., Fransson J., Scheynius A. IL-13 over-expression in skin is not confined to IgE-mediated skin inflammation. Clin Exp Immunol 1997, 109:526-532.
46. Kiyohara C., Tanaka K., Miyake Y. Genetic susceptibility to atopic dermatitis. Allergol Int 2008, 57:39-56.
47. Beck L.A., Thaci D., Hamilton J.D., Graham N.M., Bieber T., Rocklin R., Ming J.E., Ren H., Kao R., Simpson E., et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med 2014, 371:130-139.
48. Nakamura Y., Oscherwitz J., Cease K.B., Chan S.M., Munoz-Planillo R., Hasegawa M., Villaruz A.E., Cheung G.Y., McGavin M.J., Travers J.B., et al. Staphylococcus delta-toxin induces allergic skin disease by activating mast cells. Nature 2013, 503:397-401.
49. Aly R., Maibach H.I., Shinefield H.R. Microbial flora of atopic dermatitis. Arch Dermatol 1977, 113:780-782.
50. Lantz C.S., Boesiger J., Song C.H., Mach N., Kobayashi T., Mulligan R.C., Nawa Y., Dranoff G., Galli S.J. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998, 392:90-93.
51. Townsend J.M., Fallon G.P., Matthews J.D., Smith P., Jolin E.H., McKenzie N.A. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 2000, 13:573-583.
52. Iwasaki M., Nagata K., Takano S., Takahashi K., Ishii N., Ikezawa Z. Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. J Investig Dermatol 2002, 119:609-616.
53. Kaminishi K., Soma Y., Kawa Y., Mizoguchi M. Flow cytometric analysis of IL-4, IL-13 and IFN-gamma expression in peripheral blood mononuclear cells and detection of circulating IL-13 in patients with atopic dermatitis provide evidence for the involvement of type 2 cytokines in the disease. J Dermatol Sci 2002, 29:19-25.
54. Hussein Y.M., Shalaby S.M., Nassar A., Alzahrani S.S., Alharbi A.S., Nouh M. Association between genes encoding components of the IL-4/IL-4 receptor pathway and dermatitis in children. Gene 2014, 545:276-281.
55. Finkelman F.D., Katona I.M., Urban J.F., Holmes J., Ohara J., Tung A.S., Sample J.V., Paul W.E. IL-4 is required to generate and sustain in vivo IgE responses. J Immunol 1988, 141:2335-2341.
56. Oliphant C.J., Hwang Y.Y., Walker J.A., Salimi M., Wong S.H., Brewer J.M., Englezakis A., Barlow J.L., Hams E., Scanlon S.T., et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 2014, 41:283-295.
57. Gao P.S., Rafaels N.M., Mu D., Hand T., Murray T., Boguniewicz M., Hata T., Schneider L., Hanifin J.M., Gallo R.L., et al. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol 2010, 125. 1403-1407 e1404.
58. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., Gilliet M., Ho S., Antonenko S., Lauerma A., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002, 3:673-680.
59. Bell B.D., Kitajima M., Larson R.P., Stoklasek T.A., Dang K., Sakamoto K., Wagner K.U., Kaplan D.H., Reizis B., Hennighausen L., et al. The transcription factor STAT5 is critical in dendritic cells for the development of TH2 but not TH1 responses. Nat Immunol 2013, 14:364-371.
60. Li M., Hener P., Zhang Z., Kato S., Metzger D., Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci U S A 2006, 103:11736-11741.
61. Zheng T., Oh M.H., Oh S.Y., Schroeder J.T., Glick A.B., Zhu Z. Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. J Investig Dermatol 2009, 129:742-751.
62. Zhu Z., Oh M.H., Yu J., Liu Y.J., Zheng T. The role of TSLP in IL-13-induced atopic march. Sci Rep 2011, 1:23.
63. Gold M.J., Antignano F., Halim T.Y., Hirota J.A., Blanchet M.R., Zaph C., Takei F., McNagny K.M. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. J Allergy Clin Immunol 2014, 133. 1142-1148 e1145.
64. Halim T.Y., Steer C.A., Matha L., Gold M.J., Martinez-Gonzalez I., McNagny K.M., McKenzie A.N., Takei F. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 2014, 40:425-435.
65. Adkins B., Leclerc C., Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004, 4:553-564.
66. Zaghouani H., Hoeman C.M., Adkins B. Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol 2009, 30:585-591.
67. + cells are poised for rapid Th2 effector-like function. J Immunol 2007, 178:2667-2678.
68. Lee H.H., Hoeman C.M., Hardaway J.C., Guloglu F.B., Ellis J.S., Jain R., Divekar R., Tartar D.M., Haymaker C.L., Zaghouani H. Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. J Exp Med 2008, 205:2269-2280.